Company intelligence / Profile preview

Systems Oncology

Scottsdale, Arizona, United Statessystemsoncology.com ↗
Ownership
Private
Employees
~50
Development stage
Other
01

Overview

Systems Oncology is developing multiple cancer therapeutic programs, including a promising breast cancer drug preparing to enter clinical trials and a novel drug licensed to Toray projected to be effective across many cancer indications[3]

Therapeutic areas
Oncology
Modalities
Multimodal RNA therapeutics
Industry
Biotech
02

Drug pipeline

2 assets

DIM-C

Preclinical

1 more asset in the full pipeline.

03

Partnerships

Toray (Japanese company)Texas A&Mnegotiations with "one of the top pharmaceutical companies"[3][4]

Beyond the preview

Go deeper on Systems Oncology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Systems Oncology.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call